Latest filing published 03 Nov 2021 for Xilio Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
SV7 Impact Medicine Fund LP: trading record in brief
This profile gathers the share dealings of SV7 Impact Medicine Fund LP in Xilio Therapeutics, Inc. In total, 10 filings cover trades dated 26 October 2021.
On the market, this insider has only ever bought: 2 purchases, €8.6M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 3 November 2021, reports a transaction in Xilio Therapeutics, Inc. The most recent open-market purchase was published on 3 November 2021, 1,832 days ago. Typically, a trade is published a median of 8 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to SV7 Impact Medicine Fund LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 998,544 sharesCommon StockSEC:0000899243-21-042710:1
- 302,588 sharesCommon StockSEC:0000899243-21-042710:2
- 302,588 sharesCommon StockSEC:0000899243-21-042710:3
- ▲
Same trade as the filing by Bay City Capital LLC, counted once
5M USD31SEC312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-042710:4Canonical exit: 24 Jan 2022 (T+90) - 998,544 sharesCommon StockSEC:0000899243-21-042710:0
- 998,544 sharesCommon StockSEC:0000899243-21-041838:1
- 302,588 sharesCommon StockSEC:0000899243-21-041838:2
- 302,588 sharesCommon StockSEC:0000899243-21-041838:3
- 998,544 sharesCommon StockSEC:0000899243-21-041838:0
9 of 8 declarations
